Hepatitis A virus (HAV) is a highly contagious pathogen that causes acute viral hepatitis, particularly in children living in regions with poor sanitation and limited access to clean water. Unlike other hepatitis viruses, HAV does not lead to chronic infection or long-term liver damage, but its public health impact remains significant due to its ease of transmission and potential for outbreaks. In pediatric populations, HAV infection is often asymptomatic or mild, yet it plays a critical role in community spread.
HAV is a small, single-stranded RNA virus belonging to the Picornaviridae family. It is nonenveloped, which contributes to its environmental stability and resistance to detergents and gastric acid. This structural resilience allows HAV to survive on surfaces and in water for extended periods, facilitating fecal–oral transmission.
HAV is endemic in many developing countries, particularly those with inadequate sanitation infrastructure. In these regions, most children acquire the infection early in life, often without symptoms, and develop lifelong immunity. In contrast, improved sanitation and widespread vaccination have dramatically reduced HAV incidence in high-income countries.
In the United States, the introduction of routine childhood vaccination in 1996 led to a steep decline in HAV cases. According to CDC surveillance, rates of HAV infection dropped by over 90% in the two decades following vaccine implementation. However, outbreaks still occur, especially among unvaccinated populations, travelers to endemic areas, and individuals experiencing homelessness or substance use disorders.
HAV is transmitted primarily via the fecal–oral route. In children, this often occurs through close personal contact, contaminated food or water, or exposure in daycare settings. The virus is shed in stool for several weeks before and after symptom onset, making asymptomatic carriers a key source of transmission.
Although rare, perinatal transmission has been documented. In such cases, neonates may present with cholestasis, though this is an uncommon manifestation. Importantly, HAV is not transmitted via blood or sexual contact in the same manner as hepatitis B or C.
The clinical presentation of HAV varies by age. In young children, especially those under six years old, infection is frequently asymptomatic or minimally symptomatic. When symptoms do occur, they typically include:
Nausea and anorexia
Low-grade fever
Malaise and fatigue
Abdominal discomfort, particularly in the right upper quadrant
Jaundice (more common in older children and adults)
Dark urine and pale stools
Elevated serum aminotransferases (AST and ALT)
In older children and adolescents, the illness may resemble adult hepatitis, with more pronounced jaundice and systemic symptoms. The disease is self-limited, and fulminant hepatic failure is exceedingly rare in immunocompetent pediatric patients.
The diagnosis of acute HAV infection is confirmed serologically. The gold standard is detection of serum anti-HAV immunoglobulin M (IgM), which becomes positive shortly after symptom onset and remains detectable for up to six months.
Serum anti-HAV immunoglobulin G (IgG) indicates past infection or successful vaccination. IgG persists for life and confers protective immunity. Liver function tests typically show elevated transaminases, and bilirubin may be elevated in icteric cases.
Unlike hepatitis B and C, HAV does not establish chronic infection. There is no carrier state, and once the acute illness resolves, the virus is cleared completely. Relapsing hepatitis A has been described, where symptoms and liver enzyme elevations recur weeks after initial recovery, but this phenomenon is rare and self-limited.
The prognosis in children is excellent, with full recovery expected in nearly all cases. Hospitalization is uncommon unless dehydration or severe symptoms occur.
Management of HAV in children is supportive. There are no antiviral therapies approved for HAV. Treatment focuses on:
Maintaining hydration and nutrition
Managing nausea and discomfort
Monitoring liver function in severe cases
Hospitalization may be warranted for children with persistent vomiting, dehydration, or signs of hepatic dysfunction, but most cases can be managed at home.
Prevention of HAV relies on two pillars: hygiene and vaccination.
Handwashing with soap and water, especially after diaper changes and before food preparation, is critical. In daycare and school settings, strict sanitation protocols help limit spread.
The HAV vaccine is a highly effective inactivated vaccine recommended for all children beginning at 12 months of age. It is administered in two doses, spaced 6–18 months apart. The vaccine is also indicated for:
International travelers to endemic regions
Children with chronic liver disease
Close contacts of infected individuals
Children in communities with recent outbreaks
Vaccination provides long-term protection and is well tolerated, with minimal adverse effects.
For individuals recently exposed to HAV, postexposure prophylaxis can prevent illness if administered promptly. Options include:
HAV vaccine: Preferred for healthy individuals aged 12 months to 40 years
Immune globulin (IG): Recommended for infants under 12 months, immunocompromised individuals, or those with chronic liver disease
Prophylaxis should be given within two weeks of exposure for optimal efficacy.
Mothers infected with HAV can safely breastfeed their infants. The virus is not transmitted through breast milk, and with proper hygiene—especially handwashing after diaper changes and toileting—there is minimal risk of transmission.
Hepatitis A remains a significant global health concern, particularly in regions with poor sanitation. In pediatric populations, the disease is often mild or asymptomatic, yet children play a central role in transmission. Vaccination has transformed the epidemiology of HAV in developed countries, making it a cornerstone of public health strategy. Clinicians should maintain awareness of HAV’s clinical features, diagnostic criteria, and prevention strategies to ensure timely recognition and control of outbreaks.